Company news

Korro Bio, Inc. news in 2024

Korro Bio, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency

November 20, 2024

Korro to Present at the Jefferies London Healthcare Conference

November 13, 2024

Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates

November 11, 2024

Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board

November 3, 2024

Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society

September 29, 2024

Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates

September 15, 2024

Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors

August 27, 2024

Korro to Participate in Upcoming September Investor and Scientific Conferences

August 26, 2024

Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates

August 12, 2024

Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes

June 30, 2024

Korro to Participate in Upcoming June Investor and Scientific Conferences

May 29, 2024

Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference

May 19, 2024

Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer

May 13, 2024

Korro Announces $70 Million Private Placement

April 17, 2024

Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress

March 25, 2024

Korro to Present at the TD Cowen 44th Annual Health Care Conference

February 26, 2024

Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio

January 17, 2024

Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 3, 2024

Decks in 2024